Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.18
+0.18 (2.57%)
At close: Nov 6, 2026, 4:00 PM EST
7.31
+0.13 (1.81%)
After-hours: Nov 6, 2026, 5:32 PM EST

Kazia Therapeutics Revenue

Kazia Therapeutics had revenue of 14.01M AUD in the half year ending December 31, 2025, with 280,273,160.00% growth. In the fiscal year ending June 30, 2025, Kazia Therapeutics had annual revenue of 1.83M, down -26.30%. That makes Kazia Therapeutics the 43,229th largest company in the world by revenue and 5,993rd in the United States.

Revenue (ttm)
1.83M AUD
Revenue Growth
-26.30%
P/S Ratio
77.69
Revenue / Employee
304,853 AUD
Employees
6
Market Cap
98.39M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.83M-652.76K-26.30%
Jun 30, 20242.48M2.48M248,088.20%
Jun 30, 20231.00K-24.00K-96.00%
Jun 30, 202225.00K-15.16M-99.84%
Jun 30, 202115.19M14.19M1,426.13%
Jun 30, 2020995.00K-470.00K-32.08%
Jun 30, 20191.47M-11.64M-88.82%
Jun 30, 201813.11M4.30M48.75%
Jun 30, 20178.81M4.74M116.46%
Jun 30, 20164.07M1.23M43.24%
Jun 30, 20152.84M2.41M562.47%
Jun 30, 2014429.00K-1.30M-75.20%
Jun 30, 20131.73M-644.00K-27.13%
Jun 30, 20122.37M52.00K2.24%
Jun 30, 20112.32M-7.59M-76.58%
Jun 30, 20109.92M7.41M295.97%
Jun 30, 20092.50M-12.40M-83.20%
Jun 30, 200814.91M-5.10M-25.49%
Jun 30, 200720.01M1.77M9.69%
Jun 30, 200618.24M560.00K3.17%
Jun 30, 200517.68M--